Medicolegal Risk in Microsuction: What Every Practitioner Should Know

Key Takeaways:

• Three factors have shifted the medicolegal landscape: ENT UK formalised noise as a risk, independent data quantifies exposure at 118.3 dB, and quieter alternatives now exist
• The Bolam/Bolitho standard of care test now considers updated clinical guidance, published acoustic data, and available equipment when assessing negligence
• Consent forms that do not mention noise exposure are increasingly difficult to defend in clinical negligence claims
• High-risk populations (tinnitus patients, hearing aid users, children, elderly) heighten the foreseeability of harm and the duty to mitigate

The Changing Medicolegal Landscape

Ear wax removal by microsuction has long been considered a low-risk, routine procedure. That perception is now being challenged — not because the procedure itself has changed, but because our understanding of the risks has evolved, clinical guidance has been updated, and patients are increasingly aware of their rights.

For microsuction practitioners, the medicolegal environment has shifted in three important ways:

1. ENT UK has formalised noise as a clinical risk — what was previously an accepted byproduct of the procedure is now a documented hazard
2. Independent testing data quantifies the exposure — the noise levels patients experience are no longer a matter of opinion but of measurement
3. Quieter alternatives are commercially available — the defence that high noise is unavoidable no longer holds

These three factors, taken together, create a new standard against which practitioner conduct will be assessed.

Where Claims Arise

Noise-Related Complications

The most common source of medicolegal exposure in microsuction relates to acoustic harm. Patients may experience:

• Tinnitus — new onset or worsening of existing tinnitus following a procedure
• Temporary threshold shift — short-term hearing reduction caused by noise exposure
• Hearing loss — in rare cases, permanent hearing damage
• Hyperacusis — increased sensitivity to everyday sounds
• Psychological impact — anxiety, sleep disturbance, and reduced quality of life associated with tinnitus or hearing changes

Traditional microsuction devices generate noise levels of up to 140 dB inside the ear canal, with overall procedure averages of 118.3 dB (Laeq) and peak levels averaging 150.6 dB (Cpeak) based on University of Salford testing data. These levels are well above the thresholds at which occupational hearing protection is legally required in workplace settings.

Consent Failures

A significant proportion of clinical negligence claims relate not to the quality of treatment itself, but to inadequate informed consent. In the context of microsuction, consent failures may include:

• Failure to discuss the risk of noise-related complications
• Failure to mention the possibility of tinnitus, hearing changes, or vertigo
• Failure to conduct additional risk assessment for patients with pre-existing hearing conditions
• Consent forms that are generic rather than procedure-specific

The ENT UK 2024 guidance strengthens the expectation that informed consent should explicitly address acoustic risks. A consent form that does not mention noise is increasingly difficult to defend.

Equipment Choices

A practitioner’s choice of equipment is a component of their standard of care. Where updated clinical guidance recommends considering equipment noise, and where quieter alternatives are available, a decision to continue using high-noise equipment may be scrutinised in the event of a claim.

This does not mean that every practitioner must immediately replace their equipment. But it does mean that the decision to continue using existing equipment should be documented, reviewed periodically, and supported by a risk assessment.

The Standard of Care Test

Clinical negligence claims in England are assessed against the standard established by the Bolam test (1957) as refined by Bolitho (1997): would a responsible body of practitioners, acting reasonably and logically, have acted in the same way?

The key question is not what the best practitioners do, but what a reasonable practitioner would do given the available evidence and guidance.

In the context of microsuction noise, the standard of care is informed by:

• ENT UK 2024 guidance — the relevant professional body has identified noise as a risk and expects practitioners to address it
• University of Salford data — independent testing quantifies the noise exposure from traditional versus modern devices
• Available alternatives — devices operating at ≤75 dB exist and are commercially accessible

A practitioner who can demonstrate awareness of these factors, has documented their risk assessment, maintains appropriate consent processes, and has considered equipment alternatives is in a strong position. One who cannot is more vulnerable.

Risk Factors That Increase Exposure

Certain practice characteristics create higher medicolegal risk:

High-Risk Patient Populations

Practices serving patients with pre-existing hearing conditions face elevated exposure. These patients are more likely to experience adverse effects from noise, and the foreseeability of harm is greater. This includes:

• Patients with tinnitus
• Hearing aid users
• Patients referred from audiology for wax removal prior to assessment
• Elderly patients with age-related hearing loss
• Children

High-Volume Practices

Practices performing a large number of microsuction procedures have a correspondingly higher probability of encountering an adverse event. Statistical probability, combined with any documentation weakness, creates cumulative risk.

Solo Practitioners

Independent practitioners may lack the governance infrastructure of larger organisations. Without formal audit processes, incident reporting, and peer review, documentation gaps are more likely — and harder to defend.

Protecting Your Practice

1. Consent That Covers Acoustic Risk

Your consent process should:

• Specifically mention noise exposure during microsuction
• Identify potential consequences: tinnitus, temporary hearing changes, vertigo
• Be adapted for high-risk patients (e.g., pre-existing tinnitus)
• Be documented in the clinical record
• Be discussed verbally, not just signed

2. Equipment Governance

Your equipment choices should be:

• Documented with specifications (particularly noise levels)
• Supported by independent testing data where available
• Reviewed periodically against current clinical guidance
• Justified in a written risk assessment

3. Adverse Event Recording

Every noise-related complaint or symptom should be:

• Recorded in the clinical notes
• Reported through your incident reporting system
• Reviewed to identify patterns or trends
• Used to inform equipment and practice decisions

4. Clinical Audit

Regular audit of microsuction outcomes demonstrates proactive governance:

• Track complication rates (noise-related complaints, tinnitus reports, vertigo)
• Compare your rates against published data
• Document any actions taken as a result of audit findings
• Use audit evidence to support equipment review decisions

5. Professional Indemnity

Ensure your professional indemnity insurance explicitly covers microsuction procedures and that your insurer is aware of your practice volume. Review your cover annually.

Responding to a Complaint

When a patient reports a noise-related complication:

1. Document the complaint immediately — record what the patient reports, when symptoms started, and any relevant clinical history
2. Acknowledge the patient’s experience — empathy is not an admission of liability
3. Review the clinical record — check consent documentation, clinical notes, and equipment used
4. Report through your incident system — this creates a contemporaneous record and triggers review
5. Seek advice early — contact your indemnity provider if the complaint may escalate
6. Do not alter records — this is a serious professional conduct issue and will be detected

The Direction of Travel

The medicolegal landscape for microsuction is moving in one direction. Professional guidance is becoming more explicit about noise risk. Independent testing data is quantifying the exposure. Quieter equipment is available. Patients are increasingly informed and empowered.

Practitioners who act now to address acoustic risk — through better consent, equipment governance, and clinical audit — are protecting their patients and themselves. Those who wait until a claim arrives will find that the standard of care has moved on without them.

Taking Action

1. Review your consent forms — do they explicitly address noise exposure and its potential consequences?
2. Document your equipment — can you state the noise level of your devices and reference independent data?
3. Assess your patient population — are you identifying and managing high-risk patients appropriately?
4. Start auditing — even simple outcome tracking demonstrates governance
5. Evaluate quieter equipment — if your current devices lack independent noise data or ENT UK 2024 compliance, consider what options exist